Sonia Glennie
Nurse Practitioner · Seattle, WANPI 1467083287
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $55,908 of the $78,329 with a category attached, or 71.4%. 16 manufacturers reported payments, led by Pharmacyclics LLC, An Abbvie Company at 35.9% of the total. Reporting peaked in 2022 at $44,216 and has fallen 98.9% since, to $487 in 2025. Among nurse practitioner clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $389.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharmacyclics LLC, An Abbvie Company$28K
- Johnson & Johnson$22K
- AstraZeneca$16K
- Seagen Inc.$4K
- AbbVie$3K
- Bristol Myers Squibb$2K
- plus $2K from 10 others
What the payments were for
- Consulting fees$4,2505%
- Speaking & faculty fees$55,90871%
- Travel & lodging$12,46216%
- Food & beverage$5,7007%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | 62 | $28,103 |
| Johnson & Johnson | 46 | $22,364 |
| AstraZeneca | 35 | $16,120 |
| Seagen Inc. | 12 | $4,247 |
| AbbVie | 24 | $2,855 |
| Bristol Myers Squibb | 10 | $2,409 |
| E.r. Squibb & Sons, L.L.C. | 3 | $1,721 |
| Secura Bio, Inc. | 1 | $146 |
| GSK | 1 | $116 |
| Janssen Scientific Affairs, LLC | 1 | $116 |
| Morphosys, US Inc. | 1 | $32 |
| Beone Medicines USA, Inc. | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $20 |
| Acceleron Pharma, Inc. | 1 | $16 |
| EUSA Pharma (US) LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$78,329 in reported general payments places this provider in the 95th percentile of 2,466 nurse practitioner providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 20 | $382 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Seattle
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Lia Duque Estrada de BarrosSeattle$43K
- Vanessa DunleavySeattle$34K
- Lyne Schaefer AlfonseSeattle$18K
- Amy PerezSeattle$14K
- Mei Kuen Erica ToSeattle$13K
- Omeid HeidariSeattle$13K
- Cayla AlexanderSeattle$13K
- Adrianne MaurerSeattle$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.